Literature DB >> 7610877

Time course of vestibular function in patients with menière's disease following vestibular nerve section.

I Koizuka1, J Yamakawa, H Naramura, T Kubo.   

Abstract

Harmonic acceleration rotational test and vestibular autorotation test (VAT) were performed on 8 patients with Menière's disease before and after vestibular nerve section. Sinusoidal rotations of 0.01-0.64 Hz were used in the HA rotational test. VAT was performed at frequencies between 0.5 and 6 Hz. Two weeks after operation, almost all the patients consistently showed response asymmetry toward the healthy ear at all stimulus frequencies and a reduction in sensitivity to rotational stimuli at 0.01 Hz in the HA rotational test. Prior to surgery, the time constant of the vestibulo-ocular reflex (VOR) varied according to the residual vestibular function of each patient. The time constant then dropped to a mean of 4.2 s after the operation. In the VAT, almost all the patients showed a gain reduction at all frequency ranges on the seventh postoperative day. These findings suggest that response asymmetry and gain at 0.01 Hz in the HA rotational test are valuable for evaluating the time course of the compensation of the vestibular function after surgery and that the VOR time constant is useful in detecting whether the vestibular nerve has been sectioned correctly.

Entities:  

Mesh:

Year:  1995        PMID: 7610877     DOI: 10.3109/00016489509121913

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  2 in total

1.  Characterization of age-related changes in sacculocolic response parameters assessed by cervical vestibular evoked myogenic potentials.

Authors:  Niraj Kumar Singh; Ranjitha S Kashyap; L Supreetha; V Sahana
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-28       Impact factor: 2.503

2.  Use of a visual guide to improve the quality of VOR responses evoked by high-velocity rotational stimuli.

Authors:  Claire C Gianna-Poulin; Robert J Peterka
Journal:  J Vestib Res       Date:  2008       Impact factor: 2.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.